Militia Capital Management LLC Invests $2.84 Million in Acadia Healthcare Company, Inc. $ACHC

Militia Capital Management LLC acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 121,500 shares of the company’s stock, valued at approximately $2,842,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wellington Management Group LLP boosted its position in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after purchasing an additional 3,815,471 shares during the period. UBS Group AG lifted its stake in shares of Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after buying an additional 350,484 shares during the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $47,960,000. Finally, Invenomic Capital Management LP boosted its holdings in shares of Acadia Healthcare by 71.0% during the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after buying an additional 1,375,647 shares during the period.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Guggenheim lifted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday. UBS Group raised their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. KeyCorp lifted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research note on Monday, May 4th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Acadia Healthcare in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $29.62 on Monday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The company has a market cap of $2.76 billion, a PE ratio of -2.38, a price-to-earnings-growth ratio of 9.61 and a beta of 0.64. The firm has a fifty day moving average price of $28.23 and a two-hundred day moving average price of $23.81. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business’s revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Analysts expect that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.